Lexaria Bioscience Corp., 2025-10-01
An SEC Form D private-offering notice from Kelowna, BC, Canada, a $4,000,000 filer-stated offering target in Biotech. Filed 2025-10-01. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Developer of DehydraTECH, a drug delivery technology platform that improves the bioavailability of active pharmaceutical ingredients.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Alto Labs LLC, 2025-10-02, $400K, Los Angeles, CA
- Ansa Biotechnologies, Inc., 2025-10-02, $56.9M, Emeryville, CA
- Kilele Health Inc., 2025-10-01, $2M, Oakwood, OH
- Tinos Therapeutics, Inc., 2025-09-26, $4M, Cambridge, MA
- Apnimed, Inc., 2025-09-24, $35M, Cambridge, MA
- Dewpoint Therapeutics, Inc., 2025-09-23, $82.3M, Boston, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.